US Patent 9682052 Neprilysin inhibitors

Patent 9682052 was granted and assigned to Theravance on June, 2017 by the United States Patent and Trademark Office.

Is a

Current Assignee

Patent Jurisdiction

Patent Number

Date of Patent

June 20, 2017

Patent Application Number

14838842

Date Filed

August 28, 2015

Patent Citations Received

Patent Primary Examiner

Patent abstract

In one aspect, the invention relates to compounds having the formula:

No Timeline data yet.

Title

Author

Link

Type

Date

No Further Resources data yet.

Find more entities like US Patent 9682052 Neprilysin inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.